medac GmbH zeichnet vier wegweisende gemeinschaftliche Forschungsleistungen am Leibniz-HKI aus
Am Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie (Leibniz-HKI) wurden die besten Publikationen des Instituts des Jahres 2023 mit dem medac Forschungspreis ausgezeichnet. Der Preis würdigt wegweisende Forschungsarbeiten, die in Zusammenarbeit verschiedener Teams am Leibniz-HKI entstanden sind.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/iyadrmw
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.